Team:HKU HongKong/Project/Background.html
From 2012.igem.org
(Difference between revisions)
Line 481: | Line 481: | ||
<li class="toplast"><a href="https://2012.igem.org/Team:HKU_HongKong/Human_Practise.html" style="height:26px;line-height:26px;"> Human Practise </a></li> | <li class="toplast"><a href="https://2012.igem.org/Team:HKU_HongKong/Human_Practise.html" style="height:26px;line-height:26px;"> Human Practise </a></li> | ||
</ul> | </ul> | ||
+ | <p> </p> | ||
+ | <h2 style="font-variant: normal; vertical-align: baseline; clear: left; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin: 0.7em 0px; padding: 0px"> | ||
+ | <span style="font-weight: 400; text-decoration:underline"> | ||
+ | <font face="Trebuchet MS" size="6">Abstract</font></span></h2> | ||
+ | <p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: rgb(85, 85, 85); font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> | ||
+ | </p> | ||
+ | <p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> | ||
+ | HKU’s iGEM team aims to introduce | ||
+ | an acyl homoerine lactone (AHL)-degrading genetic system into the non-biolfilm-forming | ||
+ | and non-virulent BL21 Escherichia coli strain. PvdQ, an enzyme naturally | ||
+ | produced by Pseudomonas aeruginosa, is an acylase that functions to | ||
+ | degrade long chain AHLs that bacteria like Pseudomonas putida or | ||
+ | aeruginosa itself utilize for biofilm formation. Biofilms are population | ||
+ | density-dependent structures formed by quorum sensing bacteria that | ||
+ | produce and secrete auto-inducers, which signal selective gene | ||
+ | transcription. These signaling molecules, namely the AHLs, are | ||
+ | responsible for most bacterial pathogenicity including the opportunistic | ||
+ | respiratory infections caused by P.aeuroginosa in immunocompromised | ||
+ | patients. </p> | ||
+ | <p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> | ||
+ | As a step towards combating these infections, E.coli can be effectively | ||
+ | used as a protein factory to maximize pvdQ yield in vitro or ex vivo. | ||
+ | Our most preliminary biobrick is a constitutive promoter that drives | ||
+ | baseline, exponential expression of pvdQ. This genetic pathway is | ||
+ | advantageous because the pvdQ gene is constitutively transcribed | ||
+ | regardless of environmental and endogenous factors. </p> | ||
+ | <p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: rgb(85, 85, 85); font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> | ||
+ | <font color="#232323"> This synthetic genetic pathway is an auto-inductive system where pvdQ | ||
+ | protein production will specifically depend on the presence of N-dodecanoyl-L-Homoserine | ||
+ | lactone and its coupling to the LuxR protein. Furthermore, several | ||
+ | derivatives of the genetic system design can desirably optimize pvdQ | ||
+ | yield. For instance, implementation of a positive feedback loop will | ||
+ | upregulate luxR production by the simple placement of the luxR gene | ||
+ | downstream of PluxR Larger amounts of luxR will therefore bind a greater | ||
+ | number of AHL molecules secreted by P.aeuroginosa biofilms, thereby | ||
+ | activating the acylase gene’s expression at a low cell density. Hence, | ||
+ | the final biobrick produced by iGEM HKU is an AHL-inducible acylase | ||
+ | system. </font> </p> | ||
+ | <p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> | ||
+ | Although the synthetic E.coli cannot be introduced into infected humans | ||
+ | or soil and water (sources of P.aueroginosa) itself, it can be used to | ||
+ | mass-produce pvdQ which can then be packaged into small protein-delivery | ||
+ | bores. These structures can be stimulated to efficiently release pvdQ at | ||
+ | the desired location, mimicking conventional drug-delivery systems. | ||
+ | While the mechanism of pvdQ delivery will not be addressed, it can be | ||
+ | regarded as a potential implication of HKU’s iGEM project. | ||
+ | <p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; vertical-align: baseline; color: rgb(85, 85, 85); font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> | ||
+ | <p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph"> | ||
+ | <u><font face="Trebuchet MS"> | ||
+ | <b><font size="6" color="#232323">M</font></b><font size="6" color="#232323">aterials | ||
+ | & </font></font><font face="Trebuchet MS" size="6" color="#232323"> | ||
+ | Methods</font></u></p> | ||
+ | <p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph"> | ||
+ | <i> | ||
+ | <font color="#232323">Cloning and expressing pvdQ in E. coli</font></i></p> | ||
+ | <p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">pvdQ was amplified from genomic DNA of Pseudomonas | ||
+ | Aeruginosa. A functional biobrick is constructed by combining pvdQ and | ||
+ | some regulatory elements (such as promoter and terminator). The | ||
+ | regulatory components are obtained from the iGEM Distribution Kit 2012. | ||
+ | As a result, a variety of pvdQ regulatory systems can be established. | ||
+ | Among the various regulation systems, the luxR regulation system is most | ||
+ | concerned. luxR is a gene that can encode LuxR which binds with AHLs and | ||
+ | upregulates the luxRp. As a result, in our biobrick model, the | ||
+ | expression of pvdQ will be upregulated. Increase in production of pvdQ | ||
+ | indicates an increase in acylase activity, which further degrades AHLs. | ||
+ | The product biobrick will be a AHL-inducible acylase system. PvdQ will | ||
+ | only be produced w</font></font><font size="2" color="#232323">hen AHL is present.</font></font></p> | ||
+ | <p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph"> | ||
+ | <font color="#232323"><i>Testing the inhibitory effect</i></font></p> | ||
+ | <p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph"> | ||
+ | <font color="#232323" face="Tahoma" size="2">The growth rate of monospecies biofilm of <i> | ||
+ | Pseudomonas putida</i> is used to reflect the inhibitory effect of | ||
+ | engineered <i>Escherichia coli</i>. This is because the major AHLs | ||
+ | secreted by it involve 3-oxo-C12, which is a AHL that can be degraded by | ||
+ | PvdQ and is also the major AHL produced in Pseudomonas areuginosa, the | ||
+ | pathogenic microorganism. <i>pvdQ</i> expressing E. coli will be mixed | ||
+ | with Pseudomonas putida and grown on agar plate. The reduction in | ||
+ | biofilm formation will be assayed by crystal violet assay. The next part | ||
+ | of the experiment is to add engineered E. coli to different | ||
+ | phases of biofilm to validate the role of AHLs in biofilm formation.</font></p> | ||
</body> | </body> | ||
</html> | </html> |
Revision as of 08:21, 23 September 2012